This is a working overview of GHRH analogue, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-03-10. Anything still debated is marked as such rather than presented as settled.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
| Property | Value | Notes |
|---|---|---|
| Target receptor | GHRH receptor (GHRHR) | Expressed on pituitary somatotrophs |
| Primary action | Stimulates growth hormone release | Amplifies pulse size |
| Half-life, albumin-binding form | Several days as reported | Slow release from albumin complex |
| Half-life, unmodified analog | About 30 minutes in animal estimates | Cleared by proteases and filtration |
| Common analytical approach | LC-MS/MS for peptide, immunoassay for hormones | Methods answer different questions |
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Peter V'landys was appointed Chair on 30 October 2019, replacing Peter Beattie who reverted to a commissioner role. Beattie had served as Chair since February 2018. Andrew Abdo served as Interim CEO from late April 2020 until his appointment as CEO in early September 2020.
Arby's was founded in Boardman Township, Ohio, on July 23, 1964, by brothers Forrest (1922–2008) and Leroy Raffel (1927–2023), owners of a restaurant equipment business who thought there was a market opportunity for a fast food franchise based on a dish other than hamburgers. They wanted to call their restaurants "Big Tex", but that name was already used by an Akron business. Instead, they chose the name Arby's, a phonetic pronunciation of the letters R and B, short for "Raffel brothers". The Raffel brothers opened the first new restaurant in Boardman, Ohio, on July 23, 1964. They initially served only roast beef sandwiches, potato chips, and soft drinks. Hoping to attract a more upscale clientele, Arby's interior design was intentionally more luxurious in appearance than the typical fast-food sandwich stand of the day. Arby's offered their roast beef sandwiches for 69 cents at a time when hamburger stands were charging 15 cents for a hamburger. A year later, the first Arby's licensee opened a restaurant in Akron, Ohio. Early Arby's locations featured neon signage designed to resemble a cowboy hat, often bearing the text "Arby's roast beef sandwich is delicious". This sign was designed by the Peskin Sign Co.
== Applications == Synthetic antibodies have shown their utility in a number of applications. Their use within the field of research lies predominantly in the life sciences as reagents for protein capture and as protein inhibitors. Within diagnostics they have been utilised in applications ranging from infection and cancer screening to mycotoxin detection in grain samples. Synthetic antibodies are currently the fastest growing class of therapeutics.
This part of the thyroid then first forms as the ultimopharyngeal body, which begins in the ventral fourth pharyngeal pouch and joins the primordial thyroid gland during its descent to its final location. Aberrations in prenatal development can result in various forms of thyroid dysgenesis which can cause congenital hypothyroidism, and if untreated this can lead to cretinism.
Sources: en.wikipedia.org
Incidences of partial recoil occurred at 1-week post-procedure, with no further, significant, breast volume decrease afterwards, nor at the follow-up treatment at 30-weeks post-procedure. The stable, long-term increase in breast size was 55 percent (range 15–115%). The MRI visualizations of the breasts showed no edema, and confirmed the proportionate enlargement of the adipose and glandular components of the breast-tissue matrices. Furthermore, a statistically significant decrease in body weight occurred during the study, and self-esteem questionnaire scores improved from the initial-measure scores. Because external vacuum expansion of the recipient-site tissues permits injecting large-volume fat grafts (+300 cc) to correct defects and enhance the bust, the histologic viability of the breast filler (adipocyte fat) and its volume must be monitored and maintained. The long-term, volume maintenance data reported in Breast Augmentation using Pre-expansion and Autologous Fat Transplantation: a Clinical Radiological Study (2010) indicate the technical effectiveness of external tissue expansion of the recipient site for a 25-patient study group, who had 46 breasts augmented with fat grafts. The indications included micromastia (underdevelopment), explantation deformity (empty implant pocket), and congenital defects (tuberous breast deformity, Poland's syndrome).
The biochemistry of anaerobic exercise involves a process called glycolysis, in which glucose is converted to adenosine triphosphate (ATP), the primary source of energy for cellular reactions. Anaerobic exercise may be used to help build endurance, muscle strength, and power.
== Use and effects == In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists DOPR's dose as 2.5 to 5 mg orally and its duration as 20 to 30 hours. It is said to have a very slow onset. The effects of DOPR have been reported to include closed-eye imagery, visuals, thinking changes, and insomnia and sleep disruption, among others. In one of the reports, it was described as a "heavy duty psychedelic", including strong and unignorable visuals.
However, in polluted urban areas, lichen bodies often die before reaching these later developmental stages. Morphological effects of pollution include smaller thalli, fewer and smaller apothecia, and weaker substrate attachment at later developmental stages. Rather than accelerating development under stress, as some plant species do, X. parietina exhibits retarded development of pregenerative individuals and elimination of less tolerant generative individuals. Its pollution tolerance also varies with light availability; optimal conditions appear to be in areas with low pollution and good illumination, where young generative individuals dominate and reproductive capacity is highest. The species also demonstrates high metal tolerance. A key mechanism is the immobilization of toxic metals in the apoplast (the extracellular space between the cell wall and plasma membrane), preventing them from entering living cells. Additionally, it produces protective thiol peptides, increases antioxidant production, and maintains membrane integrity under metal stress. Laboratory studies indicate differential sensitivity to various metals, with its tolerance being higher for cadmium and nickel but lower for copper and mercury. It also shows resilience to pesticide exposure, persisting in untreated gardens but declining in semi-intensive orchards and disappearing in intensively sprayed orchards. These physiological responses to various pollutants make this species valuable for environmental monitoring applications.
== Medical uses == Prednisone is used for many different autoimmune diseases and inflammatory conditions, including asthma, gout, COPD, CIDP, rheumatic disorders, allergic disorders, ulcerative colitis and Crohn's disease, granulomatosis with polyangiitis, adrenocortical insufficiency, hypercalcemia due to cancer, thyroiditis, laryngitis, severe tuberculosis, hives, eczema, lipid pneumonitis, pericarditis, multiple sclerosis, nephrotic syndrome, sarcoidosis, to relieve the effects of shingles, lupus, myasthenia gravis, poison oak exposure, Ménière's disease, autoimmune hepatitis, giant cell arteritis, the Herxheimer reaction that is common during the treatment of syphilis, Duchenne muscular dystrophy, uveitis, and as part of a drug regimen to prevent rejection after organ transplant. Prednisone has also been used in the treatment of migraine headaches and cluster headaches and for severe aphthous ulcer. Prednisone is used as an antitumor drug. Prednisone is often also prescribed as a form of treatment for sudden sensorineural hearing loss (SSNHL). Prednisone can be used in the treatment of decompensated heart failure to increase renal responsiveness to diuretics, especially in heart failure patients with refractory diuretic resistance with large doses of loop diuretics. In terms of the mechanism of action for this purpose: prednisone, a glucocorticoid, can improve renal responsiveness to atrial natriuretic peptide by increasing the density of natriuretic peptide receptor type A in the renal inner medullary collecting duct, thereby inducing a potent diuresis.
Sources: en.wikipedia.org
=== 2023–present === NPS was reconstituted on 6 August 2023 after Aleksić left the People's Party. Alongside Aleksić, members of the National Assembly Slavica Radovanović, Borislav Novaković, and Đorđe Stanković, and councillors in the City Assembly of Belgrade joined the party. Aleksić announced that the party would begin collecting signatures to again become a registered political party. On 25 August, Aleksić announced that they collected over 10,000 signatures. The party was subsequently registered in October 2023. NPS became part of the Serbia Against Violence coalition in October 2023, a coalition of political parties organising the 2023 protests.
From the first partition of Poland (1772): Polish Inflants (Latgale), the northern part of the Polotsk Voivodeship, the entire Mstsislaw Voivodeship and Vitebsk Voivodeships, and the southeastern part of the Minsk Voivodeship (about 92,000 km2) From the second partition of Poland (1793): the remaining part of the Minsk Voivodeship, the entire Kiev Voivodeship, Bracław Voivodeship and Vilnius Voivodeships, parts of Podole Voivodeship and eastern parts of the Wołyń Voivodeship and Brest Litovsk Voivodeships (about 250,000 km2) From the third partition of Poland (1795): all the territories east of the Bug River(about 120,000. km2) and after 1807 the Belostok Oblast) It consisted of 9 guberniyas: six Belarusian and Lithuanian ones that constituted the Northwestern Krai (Vilna Governorate, Kovno Governorate, Grodno Governorate, Minsk Governorate, Mogilev Governorate and Vitebsk Governorate) and three Ukrainian ones that constituted the Southwestern Krai (Volhynia Governorate, Podolia Governorate and Kiev Governorate). In the first partition, Russia gained 92,000 km2 and 1.3 million people. In the second, 250,000 km2 and 1 million people. In the third, 120,000 km2 and 1.2 million people. Overall, Russia had gained about 62 percent of the former Commonwealth territory (462,000 km2) and about 45 percent of the population (3.5 million people). The Russian partition was thus the largest and most populous of the three partitions (the other two being the Austrian Partition and the Prussian Partition).
Developmental birth defects associated with elevated AFP Omphalocele Gastroschisis Neural tube defects: elevated α-fetoprotein in amniotic fluid and maternal serum Tumors associated with elevated AFP Hepatocellular carcinoma Metastatic disease affecting the liver Nonseminomatous germ cell tumors Yolk sac tumor Other conditions associated with elevated AFP Ataxia telangiectasia: elevated AFP is used as one factor in diagnosis A peptide derived from AFP that is referred to as AFPep is claimed to possess anti-cancer properties. In the treatment of testicular cancer it is paramount to differentiate seminomatous and nonseminomatous tumors. This is typically done pathologically after removal of the testicle and confirmed by tumor markers. However, if the pathology is pure seminoma but the AFP is elevated, the tumor is treated as a nonseminomatous tumor because it contains yolk sac (nonseminomatous) components.
== Binding between UII and URP == Since they are both ligands for the same receptor, an experiment was done to determine which ligand had a higher affinity. When the binding of the two were compared and tested, URP actually had higher affinity.
Sources: en.wikipedia.org
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.
Typical endpoints include growth hormone pulse frequency and amplitude, together with insulin-like growth factor 1 concentration. Some protocols add body composition or metabolic markers. Interpretation depends on baseline hormonal status, which varies widely between individuals.
Most human data come from small, early-stage studies, and independent replication is limited. Short-term effects on growth hormone release are documented; longer-term outcomes are not well characterized. Open questions include changes in pituitary responsiveness after repeated exposure.
No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.